Merck KGaA (FRA:MRK)‘s stock had its “neutral” rating reiterated by J P Morgan Chase & Co in a research report issued to clients and investors on Wednesday.

Several other equities research analysts have also issued reports on the stock. Warburg Research set a €116.00 ($138.10) price objective on shares of Merck KGaA and gave the company a “neutral” rating in a research note on Friday, July 7th. Nord/LB reaffirmed a “neutral” rating on shares of Merck KGaA in a research note on Wednesday, June 28th. equinet AG set a €112.00 ($133.33) price objective on shares of Merck KGaA and gave the company a “neutral” rating in a research note on Monday, June 26th. Kepler Capital Markets set a €119.00 ($141.67) price objective on shares of Merck KGaA and gave the company a “buy” rating in a research note on Monday, July 31st. Finally, Commerzbank Ag set a €109.00 ($129.76) price objective on shares of Merck KGaA and gave the company a “neutral” rating in a research note on Tuesday, June 13th. Fourteen research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of €107.71 ($128.23).

Merck KGaA (FRA MRK) traded up 0.022% on Wednesday, reaching €95.623. The company’s stock had a trading volume of 1,786 shares. The stock has a 50 day moving average price of €93.50 and a 200-day moving average price of €102.64. Merck KGaA has a 1-year low of €89.00 and a 1-year high of €115.00. The company has a market capitalization of €41.57 billion and a price-to-earnings ratio of 24.928.

WARNING: This news story was originally published by American Banking News and is owned by of American Banking News. If you are accessing this news story on another site, it was illegally copied and reposted in violation of US & international copyright and trademark law. The correct version of this news story can be accessed at https://www.americanbankingnews.com/2017/09/10/j-p-morgan-chase-co-reiterates-neutral-rating-for-merck-kgaa-mrk.html.

About Merck KGaA

.

Analyst Recommendations for Merck KGaA (FRA:MRK)

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.